Our platform is a way to study fat cells outside a human or animal body, or in vitro. Our stem-cell platform, M3, is unique in its accuracy in replicating human fat cells.
Dr. David Bouck is a cell biologist who has combined his background in biology with his interest in lab automation to screen small molecules and biologics during his 13 years in drug discovery at St Jude Children's Research Hospital and Takeda Pharmaceuticals.
David's career is focused on using technology, especially lab automation, to accelerate drug discovery for patients with unmet/undermet medical needs. He is excited to be part of the MelliCell team committed to discovering new therapeutics for diabetes and obesity.
Copyright © 2024 MelliCell. All Rights Reserved.